168 related articles for article (PubMed ID: 10096736)
1. Seroepidemiologic studies of hepatitis C virus infection in a population of Okayama Prefecture screened for liver disease.
Uesugi S; Taketa K; Rimal N; Ikeda S; Kariya T; Suganuma N; Yamamoto H; Kira S
Acta Med Okayama; 1999 Feb; 53(1):31-8. PubMed ID: 10096736
[TBL] [Abstract][Full Text] [Related]
2. High Frequency of Hepatitis B Core and Surface Antibodies in Hepatitis C Virus-Infected Patients on the Screening Examination.
Suto C; Murakami H; Kobayashi Y; Nagamine T; Saitoh T; Kasamatsu T; Ogawara H; Murakami M
Rinsho Byori; 2015 Mar; 63(3):305-11. PubMed ID: 26524852
[TBL] [Abstract][Full Text] [Related]
3. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.
Shen YZ; Wang ZY; Qi TK; Jiang XY; Song W; Tang Y; Wang JR; Liu L; Zhang RF; Zheng YF; Dai ZS; Lu HZ
HIV Med; 2013 Mar; 14(3):167-75. PubMed ID: 22998624
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
[TBL] [Abstract][Full Text] [Related]
5. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of Crete.
Drositis I; Bertsias A; Lionis C; Kouroumalis E
Eur J Intern Med; 2013 Dec; 24(8):839-45. PubMed ID: 23988264
[TBL] [Abstract][Full Text] [Related]
7. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to hepatitis C virus and elevated transaminase levels in a town of hyperendemicity in Iwate, Japan.
Koyama T; Tsuda F; Ishikawa K; Oishi H; Tazawa M; Yoshizawa H; Sato S; Okamoto H
J Gastroenterol Hepatol; 1997 Jan; 12(1):67-72. PubMed ID: 9076627
[TBL] [Abstract][Full Text] [Related]
9. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis C virus antibody in an area endemic for hepatitis B virus and human T cell leukaemia virus.
Ochi S; Onji M; Shiraishi K; Ohtu K; Akao T; Yano Y; Takei N; Matsui H; Ohta Y; Umeda M
J Gastroenterol Hepatol; 1991; 6(6):599-602. PubMed ID: 1685926
[TBL] [Abstract][Full Text] [Related]
11. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
12. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
Takano S; Omata M; Ohto M; Nakamura K
Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus seroprevalence in the developmentally disabled.
Levinson WM; Wormser GP; Forseter G; Calmann M; O'Brien TA
Arch Intern Med; 1992 Nov; 152(11):2309-11. PubMed ID: 1280075
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
16. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
[TBL] [Abstract][Full Text] [Related]
18. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
20. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan.
Nishioka K; Watanabe J; Furuta S; Tanaka E; Suzuki H; Iino S; Tsuji T; Yano M; Kuo G; Choo QL
Liver; 1991 Apr; 11(2):65-70. PubMed ID: 1646928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
